Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.8x | 30.0x | −0.5x | |
PEG Ratio | 8.10 | −1.16 | 0.00 | |
Price/Book | 2.9x | 2.2x | 2.6x | |
Price / LTM Sales | 5.1x | 6.6x | 3.3x | |
Upside (Analyst Target) | 47.9% | 20.5% | 45.6% | |
Fair Value Upside | Unlock | 10.5% | 5.8% | Unlock |